BioAge Labs, a biotech startup partnering with Eli Lilly for a trial of its obesity treatment, said Tuesday it has raised $170 million in its latest funding round. The Richmond, California-based startup is one of several that are developing potential treatments for obesity. Investors have rushed to back such companies in recent months, hoping to later make a fortune when demand for weight-loss drugs increases.